BR112013033192A2 - fenilbutirato na forma retal para o tratamento de uma doença neuronal motora, um distúrbio do ciclo de úreia ou câncer - Google Patents
fenilbutirato na forma retal para o tratamento de uma doença neuronal motora, um distúrbio do ciclo de úreia ou câncerInfo
- Publication number
- BR112013033192A2 BR112013033192A2 BR112013033192A BR112013033192A BR112013033192A2 BR 112013033192 A2 BR112013033192 A2 BR 112013033192A2 BR 112013033192 A BR112013033192 A BR 112013033192A BR 112013033192 A BR112013033192 A BR 112013033192A BR 112013033192 A2 BR112013033192 A2 BR 112013033192A2
- Authority
- BR
- Brazil
- Prior art keywords
- phenylbutyrate
- rectal
- cancer
- treatment
- urea cycle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161499805P | 2011-06-22 | 2011-06-22 | |
PCT/EP2012/062152 WO2012175714A1 (en) | 2011-06-22 | 2012-06-22 | Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013033192A2 true BR112013033192A2 (pt) | 2017-08-08 |
Family
ID=46384377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013033192A BR112013033192A2 (pt) | 2011-06-22 | 2012-06-22 | fenilbutirato na forma retal para o tratamento de uma doença neuronal motora, um distúrbio do ciclo de úreia ou câncer |
Country Status (8)
Country | Link |
---|---|
US (1) | US20140187638A1 (pt) |
EP (1) | EP2723317A1 (pt) |
JP (1) | JP2014517057A (pt) |
AU (1) | AU2012273976A1 (pt) |
BR (1) | BR112013033192A2 (pt) |
CA (1) | CA2840131A1 (pt) |
RU (1) | RU2014100048A (pt) |
WO (1) | WO2012175714A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3005434A1 (en) | 2015-11-16 | 2017-05-26 | Ohio State Innovation Foundation | Methods and compositions for treating disorders and diseases using survival motor neuron (smn) protein |
US20170266115A1 (en) * | 2016-03-15 | 2017-09-21 | Acer Therapeutics Inc. | Palatable compositions including sodium phenylbutyrate and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0400184D0 (sv) | 2004-01-30 | 2004-01-30 | Fyrkloevern Scandinavia Ab | New therapeutical use |
US20060045912A1 (en) * | 2004-08-30 | 2006-03-02 | Peter Truog | 4-phenylbutyric acid controlled-release formulations for therapeutic use |
-
2012
- 2012-06-22 BR BR112013033192A patent/BR112013033192A2/pt not_active IP Right Cessation
- 2012-06-22 RU RU2014100048/15A patent/RU2014100048A/ru unknown
- 2012-06-22 JP JP2014516380A patent/JP2014517057A/ja active Pending
- 2012-06-22 CA CA2840131A patent/CA2840131A1/en not_active Abandoned
- 2012-06-22 WO PCT/EP2012/062152 patent/WO2012175714A1/en active Application Filing
- 2012-06-22 EP EP12729963.4A patent/EP2723317A1/en not_active Withdrawn
- 2012-06-22 US US14/128,346 patent/US20140187638A1/en not_active Abandoned
- 2012-06-22 AU AU2012273976A patent/AU2012273976A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2014100048A (ru) | 2015-07-27 |
CA2840131A1 (en) | 2012-12-27 |
WO2012175714A1 (en) | 2012-12-27 |
AU2012273976A1 (en) | 2014-01-16 |
US20140187638A1 (en) | 2014-07-03 |
EP2723317A1 (en) | 2014-04-30 |
JP2014517057A (ja) | 2014-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013029507A2 (pt) | método para tratar uma doença ou um distúrbio | |
BR112014032105A2 (pt) | método para o tratamento de câncer | |
BR112014007603A2 (pt) | métodos de tratamento do câncer | |
BR112015001596A2 (pt) | composição para o tratamento de hiperlipidemia que compreende oxintomodulina. | |
CO6890100A2 (es) | Tratamientos de combinación para hepatitis c | |
BR112014016732A2 (pt) | processos para tratar lama vermelha | |
BR112014028424A2 (pt) | compostos de pirimidina para o tratamento de câncer | |
DK2707030T3 (da) | Cancerbehandlinger | |
BR112013021783A2 (pt) | sutiã para tratamento com radiação | |
BR112014002200A2 (pt) | tratamento de câncer de mama | |
BR112014031806A2 (pt) | método para tratamento de câncer positivo para gd2 | |
HK1203417A1 (en) | New therapeutic approaches for treating parkinsons disease | |
BR112014000033A2 (pt) | compostos para o tratamento de dependência química | |
BR112014006419A2 (pt) | métodos para tratar um paciente com câncer, kit e artigo | |
BR112014012880A2 (pt) | tratamento imunogênico do câncer | |
BR112013030381A2 (pt) | reagentes e métodos para tratar doença dental | |
BRPI1009783A2 (pt) | compostos para o tratamento de distúrbios metabólicos. | |
BR112013031712A2 (pt) | composto, composição farmacêutica, métodos para preparar um composto e para o tratamento de um distúrbio ou uma doença. | |
BRPI1007995A2 (pt) | orto-aminoamidas para o tratamento de cãncer. | |
BRPI0922884A2 (pt) | compostos para tratamento de câncer | |
BR112012000098A2 (pt) | Processo para identificação de compostos para tratar câncer | |
BR112013025340A2 (pt) | composto, composição farmacêutica, método para tratar uma doença ou distúrbio relacionado com pi3k num indivíduo necessitado, método para tratar doença mediada por hdac e método para tratar tanto doenças mediadas por pi3k como por hdac | |
BR112015002526A2 (pt) | processo para a fabricação de isavuconazol ou ravuconazol | |
BR112012008959A2 (pt) | tratamento de terapia de combinação para infecções virais | |
BR112014009789A2 (pt) | cisteamina no tratamento da doença fibrótica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |